Clinical Trial Update: Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia [Phase 3]

View source ↗

Summary

An update on a Phase 3 efficacy study for severe hypertriglyceridemia sponsored by Trygg Pharma, Inc., with the trial's status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Snippet

Sponsor: Trygg Pharma, Inc. | Conditions: Severe Hypertriglyceridemia | Phase 3 | Status: UNKNOWN